FHTXFoghorn Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of Foghorn Therapeutics Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FHTXEsta | $248M#7 | — | — | 8.0x#4 | 36.8%#5 | 14.2%#7 | -279.5%#5 | — | — | — | -14.2%#7 | — |
| CUE | $268M#1 | — | 116.1x#9 | 9.8x#5 | 195.7%#2 | 34.6%#4 | -96.7%#4 | -1151.6%#10 | — | — | 67.1%#2 | — |
| TRDA | $267M#2 | — | 1.1x#2 | 10.5x#6 | -87.9%#10 | -319.0%#13 | -621.1%#7 | -61.6%#6 | — | — | 34.8%#6 | — |
| BCYC | — | — | — | — | 105.8%#3 | -29.5%#10 | -340.4%#6 | -42.9%#5 | -794.1%#2 | — | -46.8%#10 | — |
| LYEL | $260M#4 | — | 1.1x#1 | 7229.0x#10 | -41.0%#8 | 20.0%#6 | -748344.4%#11 | -117.4%#8 | — | — | -14.3%#8 | — |
| CAMP | $258M#5 | — | — | 73.7x#8 | 436.5%#1 | -55.2%#11 | -1502.4%#8 | — | — | — | 58.4%#4 | — |
| GLSI | $261M#3 | — | 83.7x#8 | — | — | -11.2%#8 | — | -621.1%#9 | — | — | 57.1%#5 | — |
| MGNX | $257M#6 | — | 6.0x#6 | 1.7x#3 | -0.3%#7 | -11.4%#9 | -48.7%#3 | -0.2%#2 | — | — | 161.7%#1 | — |
| AKBA | $242M#9 | — | 9.7x#7 | 1.0x#2 | 47.5%#4 | 92.4%#2 | 9.9%#1 | -21.2%#4 | — | — | -68.9%#11 | — |
| RNAC | $243M#8 | — | — | 608.1x#9 | -99.0%#11 | -68.3%#12 | -35851.3%#10 | — | — | — | — | — |
| ALXO | $241M#10 | — | 1.8x#5 | — | — | 24.6%#5 | — | -74.7%#7 | -84.4%#1 | — | 64.6%#3 | — |
| WHWK | $231M#12 | — | 1.3x#3 | 32.4x#7 | -72.5%#9 | 67.7%#3 | -1601.1%#9 | -11.3%#3 | — | — | — | — |
| NATR | $232M#11 | 13.2x#1 | 1.7x#4 | 0.5x#1 | 5.7%#6 | 153.7%#1 | 5.2%#2 | 14.3%#1 | — | 9#1 | -20.0%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice